The best indicator for Zimmer Biomet (ZBH)
We backtested 366 indicators across daily, weekly and hourly charts on real Zimmer Biomet (ZBH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
DeMarker
On the daily chart, this is the strongest risk-adjusted edge we found for Zimmer Biomet (ZBH) over ~24.8 years — beating buy-and-hold by 3.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Zimmer Biomet (ZBH) — beating buy-and-hold by 0.9% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | DeMarker ✓ | Daily | 8.5% | 0.58 | -39.1% | 71.7% | 92 | 3.4% |
| 2 | Connors RSI ✓ | Weekly | 6.2% | 0.44 | -45.9% | 64.2% | 67 | 0.9% |
| 3 | WaveTrend (8/6/4) ✓ | Daily | 6.6% | 0.42 | -55.7% | 72.2% | 97 | 1.6% |
| 4 | Intraday Momentum Index ✓ | Daily | 6.3% | 0.42 | -56.1% | 67.7% | 62 | 1.2% |
| 5 | Projection Bands ✓ | Daily | 6.1% | 0.42 | -56.2% | 70.8% | 219 | 1.0% |
| 6 | MA Envelope ✓ | Weekly | 6.5% | 0.42 | -52.1% | 70.0% | 60 | 1.2% |
| 7 | Markov Regime ✓ | Weekly | 6.6% | 0.39 | -57.3% | 51.0% | 96 | 1.4% |
| 8 | Stochastic RSI ✓ | Weekly | 4.7% | 0.38 | -37.5% | 67.6% | 37 | -0.5% |
| 9 | Supertrend (20,3) ✓ | Weekly | 5.1% | 0.36 | -44.8% | 37.5% | 16 | -0.1% |
| 10 | Stochastic Momentum Index ✓ | Daily | 4.6% | 0.35 | -50.2% | 78.4% | 102 | -0.4% |
| 11 | Supertrend (10,3) ✓ | Weekly | 4.8% | 0.35 | -47.6% | 37.5% | 16 | -0.4% |
| 12 | Fibonacci Pivots ✓ | Weekly | 4.9% | 0.35 | -37.0% | 56.7% | 201 | -0.4% |
| 13 | CCI ✓ | Daily | 4.7% | 0.34 | -51.4% | 74.6% | 118 | -0.4% |
| 14 | Pivot Points (Standard) ✓ | Weekly | 4.6% | 0.34 | -37.7% | 59.3% | 182 | -0.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Zimmer Biomet (ZBH), DeMarker on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.